THE ROLE OF UNDIFFERENTIATED DYSPLASIA OF THE CONNECTIVE TISSUE IN THE DEVELOPMENT OF THE ENTEROCUTANEOUS FISTULA

  • O.Yu. Usenko
  • Ya.Yu. Voitiv
Keywords: undifferentiated dysplasia of connective tissue, entero-colocutaneous fistula, phenotypic and biochemical markers, diagnostic criteria, comorbid factor.

Abstract

Summary. Retro- and prospective trial was based on data about 30 patients, suffering entero-colocutaneous fistula, who were treated in the Shalimov National Institute of Surgery and Transplantology during 2016-2019.  There was revealed, that the most informative phenotypical markers of undifferentiated dysplasia of the connective tissue (UDCT) in patients, with entero-colocutaneous fistula, are visceral (83,3%), vascular (70%), arrhythmic (70%) syndromes. There was founded, that direct correlation between the level of biochemical markers of the collagen biodegradation and the UDCT degree may be applied for prognostication of development and course of complications in patients, suffering entero-colocutaneous fistula. Severe degree of UDCT in the patients, entero-colocutaneous fistula, constitutes unfavorable prognostic sign and enhances the mortality by 62.5%. The presence of UDCT in the patients winh entero-colocutaneous fistula is an aggravating comorbid factor that is difficult to be treated and accompanied by high rates of lethality, which must be taken into account, choosing the adequate surgical tactics and complex pathogenetically substantiated treatment.

References

Teixeira PGR, Inaba K, Dubose J, Salim A, Brown C, Rhee P, et al. Enterocutaneous fistula complicating trauma laparotomy: A major resource burden. Am Surg. 2009;75(1):30–32.

Fischer JE. The pathophysiology of enterocutaneous fistulas. World J Surg. 1983;7:446-50.;

Schecter WP, Hirshberg A, Chang DS, et al. Enteric fistulas: principles of management. J Am Coll Surg. 2009;209:484-91.

Surgical treatment—evidence-based and problem-oriented Edited by Rene G. Holzheimer, John A. Mannick, München, Germany: W. Zuckschwerdt Verlag Munchen, 2001. 843 p.

Whelan J, Ivatury R. Enterocutaneous fistulas: an overview. Eur J Trauma Emerg Surg. 2011;37(3):251–258. doi: 10.1007/s00068-011-0097-2.

Williams LJ, Zolfaghari S, Boushey RP. Complications of Enterocutaneous Fistulas and Their Management. Clin Colon Rectal Surg. 2010;23(3):209–220. doi: 10.1055/s-0030-1263062 .

Lloyd D, Gabe S, Windsor A. Nutrition and management of enterocutaneous fistula. Br J Surg.2006;93(9):1045–1055. doi: 10.1002/bjs.5396.

Nechaeva HY, Martynov AY. Dysplazyia soedynytelnoi tkany: sovremennye podkhody k dyahnostyke y lechenyiu. Stavropol: MYA; 2017. 399 p. [In Russian].

Usenko OYu, Voitiv Ya.Yu. Chastota ta kryterii diahnostyky nedyferentsiiovanoi dysplazii spoluchnoi tkanyny u khvorykh khirurhichnoho statsionaru. Klinichna khirurhiia. 2017; 10: 5-7. [In Ukrainian]. DOI: https://doi.org/10.26779/2522-1396.2017.10.05.

Patent of Ukraine No. 120158 UA, IPC А61В 8/12 (2017) The method for the diagnosis of undifferentiated dysplasia of the connective tissue / Usenko O.Yu., Voitiv Y.Yu., Shcherbina S.I.; No. u2017 03889; declared 04/20/2017; publ. 10/25/2017, Bull.№20, 2017.

Kaushal M, Carlson G L. Management of enterocutaneous fistulas. Clin Colon Rectal Surg.2004;17(2):79–88.

Boyko VV, Kryvoruchko IA, Povelychenko MS, Ianova YuV. Khirurhichne likuvannia khvorykh z urakhuvanniam prohnozu perebihu abdominalnoho sepsysu. Kharkivska khirurhichna shkola. 2014; 3: 54-58. [In Ukrainian].

Published
2019-12-25
How to Cite
Usenko, O., & Voitiv , Y. (2019). THE ROLE OF UNDIFFERENTIATED DYSPLASIA OF THE CONNECTIVE TISSUE IN THE DEVELOPMENT OF THE ENTEROCUTANEOUS FISTULA. Kharkiv Surgical School, (5-6), 5-10. https://doi.org/10.37699/2308-7005.5-6.2019.01
Section
ORIGINAL RESEARCHES